<DOC>
	<DOCNO>NCT01106131</DOCNO>
	<brief_summary>The purpose study prove effect glucose reduction CKD-501 metformin combination treatment group non inferiority compare pioglitazone metformin combination .</brief_summary>
	<brief_title>Efficacy Safety CKD-501 Versus Pioglitazone When Added Metformin</brief_title>
	<detailed_description>The aim phase 3 study evaluate efficacy safety CKD-501 metformin combination 24 week type 2 diabetes mellitus . Furthermore , extension study additional 28weeks design confirm long term safety CKD-501 oral hypoglycemic agent .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Between 18 year 80 year old ( male female ) Type Ⅱ diabetes mellitus The patient take oral hypoglycemic agent since 2 month HbA1c 7 10 % screen test BMI 21kg/㎡ 40kg/㎡ Cpeptide level 1.0 ng/ml Agreement write informed consent Type I diabetes secondary diabetes Continuous non continuous treatment ( 7 day ) insulin within 3 month prior screen Treatment thiazolidinediones within 60 day patient experience hypersensitivity reaction , serious adverse event effect treatment glitazones Chronic ( continuous 7 day ) oral non oral corticosteroid treatment within 1 month prior screen Past history : lactic acidosis metformin contraindication Acute chronic metabolic acidosis include diabetic ketoacidosis History proliferative diabetic retinopathy Severe infection , severe injury patient ( pre post operation ) Oligotrophy , starvation , hyposthenia , pituitary insufficiency capsular insufficiency Drug abuse history alcoholism History myocardial infarction , heart failure , cerebral infarction , hematencephalon unstable angina within 6 month Fasting Plasma Glucose level 270 mg/dl Triglyceride level 500 mg/dl Significant abnormal liver dysfunction : AST , ALT level equal 2.5 time , Total bilirubin level equal 2 time high upper normal limit ( UNL ) Significant abnormal renal dysfunction Anemia Abnormality thyroid function ( significant normal TSH range ) Hepatitis B C test positive Pregnant woman nurse mother Has contraindication treatment Fertile woman practice contraception appropriate method Participated trial within 4 week Participating trial present In investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>